Pharmacyte Biotech Inc (PMCB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 04/30
(Values in U.S. thousands)
| 04-2025 | 04-2024 | 04-2023 | 04-2022 | 04-2021 | |
| Operating Expenses | 4,378 | 8,520 | 6,456 | 4,392 | 3,623 |
| Operating Income | -4,378 | -8,520 | -6,456 | -4,392 | -3,623 |
| Interest Expense | 0 | 0 | 0 | 1 | 3 |
| Other Income | 35,034 | 8,854 | 2,140 | 153 | 75 |
| Pre-tax Income | 30,656 | 334 | -4,316 | -4,239 | -3,551 |
| Net Income Continuous | 30,656 | 334 | -4,316 | -4,239 | -3,551 |
| Net Income | $30,656 | $334 | $-4,316 | $-4,239 | $-3,551 |
| EPS Basic Total Ops | 3.19 | -1.80 | -0.22 | -0.27 | -2.45 |
| EPS Basic Continuous Ops | 4.18 | 0.03 | -0.22 | -0.27 | -2.45 |
| EPS Diluted Total Ops | 3.19 | -1.80 | -0.22 | -0.27 | -2.45 |
| EPS Diluted Continuous Ops | 4.18 | 0.03 | -0.22 | -0.27 | -2.45 |
| EPS Diluted Before Non-Recurring Items | -1.40 | -2.36 | -0.22 | -0.27 | -2.45 |
| EBITDA(a) | $-4,378 | $-8,520 | $-6,456 | $-4,392 | $-3,623 |